HHS Seeks Increase In Sanofi-Aventis’ Fluzone Production
This article was originally published in The Pink Sheet Daily
Executive Summary
HHS is discussing with Sanofi-Aventis whether the company can boost Fluzone production to alleviate an impending flu vaccine shortage.